Concord Biotech (BOM:543960) Accounts Payable & Accrued Expense : ₹999 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Accounts Payable & Accrued Expense?

Concord Biotech's quarterly accounts payable & accrued expense declined from Mar. 2023 (₹1,363 Mil) to Sep. 2023 (₹761 Mil) but then increased from Sep. 2023 (₹761 Mil) to Mar. 2024 (₹999 Mil).

Concord Biotech's annual accounts payable & accrued expense increased from Mar. 2022 (₹1,068 Mil) to Mar. 2023 (₹1,363 Mil) but then declined from Mar. 2023 (₹1,363 Mil) to Mar. 2024 (₹999 Mil).

Concord Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Concord Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Accounts Payable & Accrued Expense Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

813.76

707.38

1,068.02

1,362.55

999.29

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			1,068.02	-	1,362.55	761.16	999.29

Concord Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines